Literature DB >> 29101602

Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat.

Inge Oberholzer1, Marisa Möller1, Brendan Holland2, Olivia M Dean3,4,5, Michael Berk3,6, Brian H Harvey7.   

Abstract

There is abundant evidence for both disorganized redox balance and cognitive deficits in major depressive disorder (MDD). Garcinia mangostana Linn (GM) has anti-oxidant activity. We studied the antidepressant-like and pro-cognitive effects of raw GM rind in Flinders Sensitive Line (FSL) rats, a genetic model of depression, following acute and chronic treatment compared to a reference antidepressant, imipramine (IMI). The chemical composition of the GM extract was analysed for levels of α- and γ-mangostin. The acute dose-dependent effects of GM (50, 150 and 200 mg/kg po), IMI (20 mg/kg po) and vehicle were determined in the forced swim test (FST) in FSL rats, versus Flinders Resistant Line (FRL) control rats. Locomotor testing was conducted using the open field test (OFT). Using the most effective dose above coupled with behavioral testing in the FST and cognitive assessment in the novel object recognition test (nORT), a fixed dose 14-day treatment study of GM was performed and compared to IMI- (20 mg/kg/day) and vehicle-treated animals. Chronic treated animals were also assessed with respect to frontal cortex and hippocampal monoamine levels and accumulation of malondialdehyde. FSL rats showed significant cognitive deficits and depressive-like behavior, with disordered cortico-hippocampal 5-hydroxyindole acetic acid (5-HIAA) and noradrenaline (NA), as well as elevated hippocampal lipid peroxidation. Acute and chronic IMI treatment evoked pronounced antidepressant-like effects. Raw GM extract contained 117 mg/g and 11 mg/g α- and γ-mangostin, respectively, with acute GM demonstrating antidepressant-like effects at 50 mg/kg/day. Chronic GM (50 mg/kg/d) displayed significant antidepressant- and pro-cognitive effects, while demonstrating parity with IMI. Both behavioral and monoamine assessments suggest a more prominent serotonergic action for GM as opposed to a noradrenergic action for IMI, while both IMI and GM reversed hippocampal lipid peroxidation in FSL animals. Concluding, FSL rats present with cognitive deficits and depressive-like behaviors that are reversed by acute and chronic GM treatment, similar to that of IMI.

Entities:  

Keywords:  Chromatographic fingerprinting; Ethnopharmacology; Inflammation; Mangosteen; Oxidative stress; Psychiatry

Mesh:

Substances:

Year:  2017        PMID: 29101602     DOI: 10.1007/s11011-017-0144-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  83 in total

Review 1.  Autoregulation of serotonin neurons: role in antidepressant drug action.

Authors:  G Piñeyro; P Blier
Journal:  Pharmacol Rev       Date:  1999-09       Impact factor: 25.468

Review 2.  A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.

Authors:  Michael Maes; Piotr Galecki; Yong Seun Chang; Michael Berk
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-05-12       Impact factor: 5.067

3.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

Review 4.  Prevalence and clinical course of depression: a review.

Authors:  Derek Richards
Journal:  Clin Psychol Rev       Date:  2011-07-23

5.  Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment.

Authors:  Moe Pwint Phyu; Jitbanjong Tangpong
Journal:  Food Chem Toxicol       Date:  2014-04-30       Impact factor: 6.023

Review 6.  Treatment of anxiety and depression: medicinal plants in retrospect.

Authors:  James O Fajemiroye; Dayane M da Silva; Danillo R de Oliveira; Elson A Costa
Journal:  Fundam Clin Pharmacol       Date:  2016-03-04       Impact factor: 2.748

7.  Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depression.

Authors:  Irina Majumder; Jason M White; Rodney J Irvine
Journal:  Behav Pharmacol       Date:  2011-12       Impact factor: 2.293

Review 8.  Cognition and depression: current status and future directions.

Authors:  Ian H Gotlib; Jutta Joormann
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

9.  Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus.

Authors:  Gislaine Z Réus; Roberto B Stringari; Bruna de Souza; Fabrícia Petronilho; Felipe Dal-Pizzol; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  Oxid Med Cell Longev       Date:  2010-09-01       Impact factor: 6.543

Review 10.  The novel object recognition memory: neurobiology, test procedure, and its modifications.

Authors:  M Antunes; G Biala
Journal:  Cogn Process       Date:  2011-12-09
View more
  10 in total

1.  Recent updates on metabolite composition and medicinal benefits of mangosteen plant.

Authors:  Wan Mohd Aizat; Ili Nadhirah Jamil; Faridda Hannim Ahmad-Hashim; Normah Mohd Noor
Journal:  PeerJ       Date:  2019-01-31       Impact factor: 2.984

2.  Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostanaLinn. (Mangosteen) Pericarp for Schizophrenia.

Authors:  Alyna Turner; John J McGrath; Olivia M Dean; Seetal Dodd; Andrea Baker; Susan M Cotton; James G Scott; Bianca E Kavanagh; Melanie M Ashton; Adam J Walker; Ellie Brown; Michael Berk
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582

3.  Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial.

Authors:  Melanie M Ashton; Michael Berk; Chee H Ng; Malcolm Hopwood; Seetal Dodd; Alyna Turner; Ellie Brown; Felice N Jacka; Susan M Cotton; Jon-Paul Khoo; Mary Lou Chatterton; Bianca E Kavanagh; Sarah E Nadjidai; Samantha L Lo Monaco; Brian H Harvey; Jerome Sarris; Gin S Malhi; Nathan L Dowling; Olivia M Dean
Journal:  Braz J Psychiatry       Date:  2018-10-11       Impact factor: 2.697

4.  Neuroprotective Effect of α-Mangostin in the Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats.

Authors:  Aarti Tiwari; Rishabh Khera; Saloni Rahi; Sidharth Mehan; Hafiz Antar Makeen; Yahya H Khormi; Muneeb U Rehman; Andleeb Khan
Journal:  Brain Sci       Date:  2021-02-25

Review 5.  The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment.

Authors:  Esmé Jansen van Vuren; Stephan F Steyn; Christiaan B Brink; Marisa Möller; Francois P Viljoen; Brian H Harvey
Journal:  Biomed Pharmacother       Date:  2021-01-01       Impact factor: 6.529

6.  Bio-behavioural changes in treatment-resistant socially isolated FSL rats show variable or improved response to combined fluoxetine-olanzapine versus olanzapine treatment.

Authors:  K Mncube; B H Harvey
Journal:  IBRO Neurosci Rep       Date:  2022-09-05

7.  Reserpine-induced altered neuro-behavioral, biochemical and histopathological assessments prevent by enhanced antioxidant defence system of thymoquinone in mice.

Authors:  Noreen Samad; Natasha Manzoor; Zahra Muneer; Sheraz A Bhatti; Imran Imran
Journal:  Metab Brain Dis       Date:  2021-07-26       Impact factor: 3.584

8.  Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats.

Authors:  Jana Lotter; Marisa Möller; Olivia Dean; Michael Berk; Brian H Harvey
Journal:  Front Psychiatry       Date:  2020-03-31       Impact factor: 4.157

Review 9.  Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles.

Authors:  Ha Thi Thu Do; Jungsook Cho
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

Review 10.  Medicinal Potential of Garcinia Species and Their Compounds.

Authors:  Bruna Larissa Spontoni do Espirito Santo; Lidiani Figueiredo Santana; Wilson Hino Kato Junior; Felipe de Oliveira de Araújo; Danielle Bogo; Karine de Cássia Freitas; Rita de Cássia Avellaneda Guimarães; Priscila Aiko Hiane; Arnildo Pott; Wander Fernando de Oliveira Filiú; Marcel Arakaki Asato; Patrícia de Oliveira Figueiredo; Paulo Roberto Haidamus de Oliveira Bastos
Journal:  Molecules       Date:  2020-10-01       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.